Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegylated Interferon for Acute HCV in HIV Patients
NCT00132210Phase 4Completed
- Sponsor
- University Hospital Bonn
- Start
- Sep 2002
- Primary completion
- Jun 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pegylated interferon alpha in hepatitis C virus infection, sponsored by University Hospital Bonn. Primary endpoints: Negative Hepatitis C Ribonucleic Acid at 24 weeks and Normal Liver Enzymes at 24 weeks. Started Sep 2002; status: completed.
02
Drugs
pegylated interferon alpha
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT00132210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00132210.